Liver Failure, Acute on Chronic Clinical Trial
Official title:
Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure
Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure
Acute-on-chronic liver failure (ACLF) which occurs in patients with chronic liver disease, is a serious live-threatening disease. Currently, the clinical management, such as liver protection, anti-virus medicine, and artificial liver support, has not significantly improve the outcomes, the mortality still remains over 50%. Liver transplantation is the only effective treatment of ACLF, but this therapy is limited by the shortage of donor organs, potential surgical complications, immunological rejection and high medical costs. Mesenchymal stem cell (MSC) is one of adult stem cells, which has been suggested to play a role in amelioration of liver disease, such as: trans-differentiation of MSCs into hepatocytes, immunomodulation, inhibition of fibrosis development, protective effects on hepatic cell and restoration of hepatic cell proliferation capacity. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT05881668 -
MSC-EV in Acute-on-Chronic Liver Failure After Liver Transplantation
|
Phase 1 | |
Recruiting |
NCT05793983 -
S100A8/A9 and Innate Immunity in Liver Disease
|
||
Completed |
NCT03641872 -
A Validation Cohort for ACLF Diagnosis and Prognosis
|
||
Recruiting |
NCT05786859 -
The Efficacy and Safety of Rifaximin Treatment
|
Early Phase 1 | |
Completed |
NCT03312036 -
HEpatic Regeneration With COupled Plasma Filtration and Adsorption for Liver Extracorporeal Detoxification
|
N/A | |
Completed |
NCT04959110 -
Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT
|
N/A | |
Completed |
NCT02457637 -
Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure Study
|
||
Completed |
NCT03281265 -
A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China
|
N/A | |
Recruiting |
NCT03281252 -
A Prospective Study of Evaluation of Minor Bleeding and Utility of Bleeding Criteria in Acute-on-chronic Liver Failure Patients in China
|
N/A |